Platform Processes May Reduce AAV Gene Therapy Costs

被引：0
|
作者：
Labant M.
机构：
来源：
Genetic Engineering and Biotechnology News | 2024年 / 44卷 / 04期
关键词：
D O I：
10.1089/gen.44.04.16
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：42 / 44and46
页数：4404
相关论文
共 50 条
  • [21] AAV gene therapy for Dravet Syndrome
    Diaz, Juan Antinao
    Counsell, John
    Morris, Gareth
    Buckley, Suzanne
    Davidge, Joanna
    Schorge, Stephanie
    Waddington, Simon
    Karda, Rajvinder
    HUMAN GENE THERAPY, 2018, 29 (07) : A9 - A9
  • [22] Immunogenicity and toxicity of AAV gene therapy
    Ertl, Hildegund C. J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] AAV gene therapy vectors in the TMJ
    Brouxhon, Sabine M.
    O'Banion, Michael Kerry
    Kyrkanides, Stephanos
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2022, 8 (06): : 1561 - 1566
  • [24] Safety questions for AAV gene therapy
    Charles P. Venditti
    Nature Biotechnology, 2021, 39 : 24 - 26
  • [25] Lyophilisation of AAV Gene Therapy Product
    Bendik, Marian
    MOLECULAR THERAPY, 2018, 26 (05) : 188 - 189
  • [26] Safety questions for AAV gene therapy
    Venditti, Charles P.
    NATURE BIOTECHNOLOGY, 2021, 39 (01) : 24 - 26
  • [27] Neutralizing the Neutralizers in AAV Gene Therapy
    Herzog, Roland W.
    Biswas, Moanaro
    MOLECULAR THERAPY, 2020, 28 (08) : 1741 - 1742
  • [28] Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system
    Gafni, Y
    Pelled, G
    Zilberman, Y
    Turgeman, G
    Apparailly, F
    Yotvat, H
    Galun, E
    Gazit, Z
    Jorgensen, C
    Gazit, D
    MOLECULAR THERAPY, 2004, 9 (04) : 587 - 595
  • [29] Synergistic combinations of muscle relaxants may reduce costs
    Woehlck, HJ
    Brown, B
    ANESTHESIA AND ANALGESIA, 1996, 82 (04): : 888 - 888
  • [30] Optical correlators - Integrated design may reduce costs
    Bains, S
    LASER FOCUS WORLD, 1999, 35 (01): : 43 - +
12345